Could a magnetic helmet ease diabetic nerve pain?
NCT ID NCT05937984
First seen Jun 10, 2026 · Last updated Jun 19, 2026 · Updated 2 times
Summary
This study tested whether a new type of brain stimulation, called controlled transcranial magnetic stimulation (cTMS), can reduce pain and improve daily function in people with painful diabetic neuropathy. Twenty adults with the condition received either real or sham cTMS over five days. The goal was to see if this non-invasive, painless procedure could offer relief where other treatments have fallen short.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAINFUL DIABETIC NEUROPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
McMaster University
Hamilton, Ontario, L8S 4L8, Canada
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
controlled transcranial magnetic stimulation (cTMS) device
What this could lead to
If it works, this could offer a new, non-drug option for managing chronic nerve pain in people with diabetes.
What could go wrong
This was a very small, early study (20 people) and previous TMS research only helped about half of patients. The results may not apply to everyone.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.